Invacare (NYSE:IVC) was upgraded by equities researchers at ValuEngine from a “sell” rating to a “hold” rating in a report released on Sunday.

A number of other research firms have also recently commented on IVC. KeyCorp reissued a “buy” rating and set a $18.00 target price on shares of Invacare in a research report on Friday, November 10th. Zacks Investment Research cut shares of Invacare from a “hold” rating to a “sell” rating in a research report on Tuesday, November 14th. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $16.00.

Invacare (NYSE IVC) traded down $0.15 during midday trading on Friday, hitting $16.85. 241,600 shares of the stock were exchanged, compared to its average volume of 482,431. Invacare has a twelve month low of $9.90 and a twelve month high of $17.95. The company has a current ratio of 2.28, a quick ratio of 1.57 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $558.80, a PE ratio of -7.20 and a beta of 2.43.

Invacare (NYSE:IVC) last posted its earnings results on Tuesday, November 7th. The health services provider reported ($0.41) EPS for the quarter, topping analysts’ consensus estimates of ($0.43) by $0.02. Invacare had a negative net margin of 7.95% and a negative return on equity of 13.33%. The business had revenue of $250.91 million for the quarter, compared to analysts’ expectations of $239.88 million. During the same period in the previous year, the company posted ($0.37) earnings per share. The business’s revenue for the quarter was down 6.4% compared to the same quarter last year. equities analysts forecast that Invacare will post -2.12 earnings per share for the current fiscal year.

Institutional investors and hedge funds have recently bought and sold shares of the stock. Municipal Employees Retirement System of Michigan raised its holdings in Invacare by 4.3% in the second quarter. Municipal Employees Retirement System of Michigan now owns 7,580 shares of the health services provider’s stock valued at $100,000 after acquiring an additional 310 shares in the last quarter. 1st Global Advisors Inc. acquired a new stake in Invacare in the second quarter valued at $138,000. BNP Paribas Arbitrage SA raised its holdings in Invacare by 39.8% in the second quarter. BNP Paribas Arbitrage SA now owns 14,646 shares of the health services provider’s stock valued at $193,000 after acquiring an additional 4,166 shares in the last quarter. Arizona State Retirement System raised its holdings in Invacare by 1.2% in the second quarter. Arizona State Retirement System now owns 16,724 shares of the health services provider’s stock valued at $221,000 after acquiring an additional 200 shares in the last quarter. Finally, AXA acquired a new stake in Invacare in the second quarter valued at $224,000. 94.65% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Invacare (IVC) Upgraded by ValuEngine to “Hold”” was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was stolen and reposted in violation of US & international trademark and copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2018/01/01/invacare-ivc-upgraded-by-valuengine-to-hold.html.

About Invacare

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Invacare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invacare and related companies with MarketBeat.com's FREE daily email newsletter.